Mesoblast (MESO) Non-Current Assets (2015 - 2025)

Mesoblast's (MESO) quarterly Non-Current Assets came in at $579.8 million in Q4 2025, down 0.65% year-on-year from $583.6 million in Q4 2024, and little changed quarter-over-quarter from $580.3 million in Q2 2025.

Mesoblast (MESO) Non-Current Assets (2015 - 2025) Analysis & Trends

Mesoblast has disclosed Non-Current Assets across 11 years of filings, most recently posting $579.8 million for Q4 2025.

  • Non-Current Assets for Q4 2025 came in at $579.8 million, down 0.65% year-over-year; the trailing twelve-month figure through Dec 2025 was $579.8 million (down 0.65% YoY), and the FY2025 annual result was $580.3 million, changed 0.4% from the prior year.
  • Non-Current Assets came in at $579.8 million for Q4 2025 at Mesoblast, roughly flat from $580.3 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $596.5 million in Q2 2021 to a low of $579.8 million in Q4 2025.
  • The 5-year median for Non-Current Assets is $589.9 million (2022), against an average of $589.3 million.
  • Across the five-year window, Non-Current Assets dropped 0.01% in 2021 and fell 0.96% in 2022, its largest moves.
  • Mesoblast's Non-Current Assets stood at $595.6 million in 2021, then dropped by 0.96% to $589.9 million in 2022, then dropped by 0.81% to $585.1 million in 2023, then decreased by 0.25% to $583.6 million in 2024, then slipped by 0.65% to $579.8 million in 2025.
  • The last three Non-Current Assets figures came in at $579.8 million (Q4 2025), $580.3 million (Q2 2025), and $583.6 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Mesoblast 21.68 Bn 21.55 Bn - 579.82 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 579.82 Mn
Jun 30, 2025 580.33 Mn
Dec 31, 2024 583.64 Mn
Jun 30, 2024 582.69 Mn
Dec 31, 2023 585.13 Mn
Jun 30, 2023 587.76 Mn
Mar 31, 2023 589.08 Mn
Dec 31, 2022 589.93 Mn
Sep 30, 2022 591.54 Mn
Jun 30, 2022 592.31 Mn
Mar 31, 2022 593.56 Mn
Dec 31, 2021 595.64 Mn
Sep 30, 2021 595.60 Mn
Jun 30, 2021 596.49 Mn
Mar 31, 2021 596.36 Mn
Dec 31, 2020 596.85 Mn
Sep 30, 2020 596.84 Mn
Jun 30, 2020 597.05 Mn
Mar 31, 2020 596.40 Mn
Dec 31, 2019 596.93 Mn